Parallax Volatility Advisers, L.P. Cue Biopharma, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $1,772 - $4,215	-712 Reduced 0.94%	75,000 $187,000
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $107,723 - $299,963	-24,427 Reduced 24.39%	75,712 $369,000
Q4 2021 Feb 14, 2022	BUY	$10.86 - $17.85 $905,886 - $1.49 Million	83,415 Added 498.77%	100,139 $1.13 Million
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $182,291 - $242,999	16,724 New	16,724 $195,000

11.9M

22K

1.2K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $36.4M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.